World’s First | Mabwell’s 9MW5211 Receives FDA Clearance for Clinical Trial Application

B SHANGHAI, May 8, 2026 /PRNewswire/ — Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the Investigational New Drug…
posteditor
posteditor
Articles: 21727

Other News